Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.

Thomas B Brunner; Gerhard G Grabenbauer; Peter Klein; Ulrich Baum; Thomas  Papadopoulos; Werner Bautz; Werner Hohenberger; Rolf Sauer

Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.

Thomas B Brunner, Gerhard G Grabenbauer, Peter Klein, Ulrich Baum, Thomas Papadopoulos (Co-Autor/-in), Werner Bautz, Werner Hohenberger, Rolf Sauer

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

43 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	144-153
Fachzeitschrift	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Jahrgang	55
Ausgabenummer	1
Publikationsstatus	Veröffentlicht - 2003

Dieses zitieren

Brunner, T. B., Grabenbauer, G. G., Klein, P., Baum, U., Papadopoulos, T., Bautz, W., Hohenberger, W., & Sauer, R. (2003). Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 55(1), 144-153.

Brunner, Thomas B ; Grabenbauer, Gerhard G ; Klein, Peter et al. / Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. in: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 2003 ; Jahrgang 55, Nr. 1. S. 144-153.

@article{8231c27093384fe7b4930cd7006caea1,

title = "Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.",

keywords = "RADIATION-THERAPY, STAGE-II, CARCINOMA, ADENOCARCINOMA, CHEMORADIOTHERAPY, CHEMORADIATION, VARIABLES, TOXICITY",

author = "Brunner, \{Thomas B\} and Grabenbauer, \{Gerhard G\} and Peter Klein and Ulrich Baum and Thomas Papadopoulos and Werner Bautz and Werner Hohenberger and Rolf Sauer",

year = "2003",

language = "English",

volume = "55",

pages = "144--153",

journal = "INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ",

issn = "0360-3016",

publisher = "Elsevier ",

number = "1",

}

Brunner, TB, Grabenbauer, GG, Klein, P, Baum, U, Papadopoulos, T, Bautz, W, Hohenberger, W & Sauer, R 2003, 'Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.', INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , Jg. 55, Nr. 1, S. 144-153.

Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. / Brunner, Thomas B; Grabenbauer, Gerhard G; Klein, Peter et al.
in: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , Jahrgang 55, Nr. 1, 2003, S. 144-153.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.

AU - Brunner, Thomas B

AU - Grabenbauer, Gerhard G

AU - Klein, Peter

AU - Baum, Ulrich

AU - Papadopoulos, Thomas

AU - Bautz, Werner

AU - Hohenberger, Werner

AU - Sauer, Rolf

PY - 2003

Y1 - 2003

KW - RADIATION-THERAPY

KW - STAGE-II

KW - CARCINOMA

KW - ADENOCARCINOMA

KW - CHEMORADIOTHERAPY

KW - CHEMORADIATION

KW - VARIABLES

KW - TOXICITY

M3 - Original Article

C2 - 12504047

SN - 0360-3016

VL - 55

SP - 144

EP - 153

JO - INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

JF - INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IS - 1

ER -

Brunner TB, Grabenbauer GG, Klein P, Baum U, Papadopoulos T, Bautz W et al. Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS . 2003;55(1):144-153.